MACKENZIE FINANCIAL CORP - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 147 filers reported holding ASCENDIS PHARMA A/S in Q4 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.8%.

Quarter-by-quarter ownership
MACKENZIE FINANCIAL CORP ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2023$409,045
-7.3%
4,653
-7.1%
0.00%0.0%
Q2 2023$441,229
-30.8%
5,006
-15.8%
0.00%0.0%
Q1 2023$637,423
-18.6%
5,945
-7.3%
0.00%0.0%
Q4 2022$783,098
+33.6%
6,412
+12.9%
0.00%0.0%
Q3 2022$586,000
+46.9%
5,679
+32.2%
0.00%0.0%
Q2 2022$399,000
+17.0%
4,295
+48.0%
0.00%
Q1 2022$341,000
-68.4%
2,902
-63.8%
0.00%
-100.0%
Q4 2021$1,080,000
-20.6%
8,026
-6.0%
0.00%
-50.0%
Q3 2021$1,360,000
+15.0%
8,535
-5.1%
0.00%0.0%
Q2 2021$1,183,000
-5.0%
8,990
-6.9%
0.00%0.0%
Q1 2021$1,245,000
-17.5%
9,660
+6.7%
0.00%
-33.3%
Q4 2020$1,509,000
+13.5%
9,050
+5.1%
0.00%0.0%
Q3 2020$1,329,000
+14.8%
8,612
+10.0%
0.00%0.0%
Q2 2020$1,158,000
+27.7%
7,829
-2.8%
0.00%0.0%
Q1 2020$907,000
-21.5%
8,053
-3.0%
0.00%0.0%
Q4 2019$1,155,000
+35.9%
8,302
-5.9%
0.00%
+50.0%
Q3 2019$850,000
-2.5%
8,822
+16.6%
0.00%0.0%
Q2 2019$872,0007,5690.00%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q4 2019
NameSharesValueWeighting ↓
RA Capital Management 5,865,338$978,221,00013.68%
Vivo Capital, LLC 1,797,745$299,828,00013.38%
Sofinnova Investments, Inc. 1,109,874$185,105,00011.02%
Avoro Capital Advisors LLC 1,800,000$300,204,0005.17%
Eventide Asset Management 1,704,148$284,218,0004.36%
Stenahm Asset Managment Ltd 29,000$4,837,0004.07%
Ghost Tree Capital, LLC 105,000$17,512,0003.90%
Eversept Partners, LP 187,043$31,195,0323.66%
Spyglass Capital Management LLC 701,594$117,012,0003.59%
Q Global Advisors, LLC 23,183$3,866,0002.72%
View complete list of ASCENDIS PHARMA A/S shareholders